ARTICLE

FindCenter AddIcon

Why Microdosing MDMA Could Be A Bad Idea

By Patrick Smith — 2017

As the trend of microdosing illustrates, if people want to reap the benefits of a substance, they’ll find the most effective way to do it. Everyone from entrepreneurs to artists are microdosing psychedelics like LSD, psilocybin, and mescaline for spiritual, creative, and productive enhancement. So could MDMA fall in among the usual microdosing suspects?

Read on thethirdwave.co

FindCenter Post-Image

Why Canada Could Be Next to Allow Psychedelic Therapy (And How It’s Already Changing Lives)

Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Therapy Schools Are Popping Up Like Mushrooms

For hundreds or thousands of dollars, you can get certified to administer mind-altering—and some say, mind-healing—drugs.

FindCenter AddIcon
FindCenter Post-Image

The Return of Psychedelics to Counseling: Are We Ready?

Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.

FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

FindCenter AddIcon
FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

FindCenter AddIcon
FindCenter Post-Image

Psilocybin Sessions: Psychedelics Could Help People with Addiction and Anxiety

Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.

FindCenter AddIcon
FindCenter Post-Image

Microdose Research: Without Approvals, Control Groups, Double-Blinds, Staff or Funding

There is an abundance of good news. After forty plus years of research being denied, what Charles Grob kindly called, “a lull,” psychedelic science is back.

FindCenter AddIcon

EXPLORE TOPIC

MDMA